Overview
- 94 inspections across 77 sites are on record.
- 308 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-04-03.
At a glance
Inspections
94
Sites
77
Observations
308
Career since
Jan 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shanghai WEIPU Testing Technology Group Co.,LTD. | 3 Apr 2024 | Human Drugs | On file |
| Zhejiang Yongtai Chiral Medicine Technology Co., Ltd. | 29 Mar 2024 | Human Drugs | On file |
| Belleview Biosciences LLC | 15 Mar 2024 | Human Drugs | View 483 → |
| Unimed Pharmaceuticals, Inc. | 14 Feb 2023 | Human Drugs | |
| Seoul Cosmetics Co., Ltd. | 3 Feb 2023 | Human Drugs | View 483 → |
Sites inspected
Shanghai WEIPU Testing Technology Group Co.,LTD.Shanghai, China1 insp.
Zhejiang Yongtai Chiral Medicine Technology Co., Ltd.Taizhou, China1 insp.
Belleview Biosciences LLCBrooksville, United States1 insp.
Unimed Pharmaceuticals, Inc.Cheongju, Korea (the Republic of)1 insp.
Seoul Cosmetics Co., Ltd.Namdong, Korea (the Republic of)1 insp.
Co-investigators
Investigators who share inspections with this person.
Samantha J Pinizzotto11 shared
Leo J Lagrotte7 shared
Daryl A Dewoskin7 shared
Mizanne E Lewis4 shared
Nicole E Knowlton4 shared
Jason P Aun4 shared
Tamara J Henderson4 shared
Laura B Kennedy4 shared
Ileana Barreto-Pettit3 shared
Jennifer A Robinson3 shared
Full investigator report
Get the verbatim findings behind Michael H Tollon's 308 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site